ALZN$1.47+17.59%
Alzamend Neuro, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$7.09M
Float & O/S:
Inst Own:
DilutionScan read 36 of Alzamend Neuro, Inc.'s SEC filings and found 7 warrant series, 4 convertibles, 3 ATM programs, 1 equity line, 2 shelf registrations, 2 S-1 registrations and 3 completed offerings on file for ALZN. The latest dilution event on file is a registration statement on Aug 21, 2026. Analysis updated Oct 29, 2026.
